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A B S T R A C T
To test the hypothesis that sleep can reverse cognitive impairment during Alzheimer's disease, we enhanced
sleep in ﬂies either co-expressing human amyloid precursor protein and Beta-secretase (APP:BACE), or in ﬂies
expressing human tau. The ubiquitous expression of APP:BACE or human tau disrupted sleep. The sleep deﬁcits
could be reversed and sleep could be enhanced when ﬂies were administered the GABA-A agonist 4,5,6,7-
tetrahydroisoxazolo-[5,4-c]pyridine-3-ol (THIP). Expressing APP:BACE disrupted both Short-term memory
(STM) and Long-term memory (LTM) as assessed using Aversive Phototaxic Suppression (APS) and courtship
conditioning. Flies expressing APP:BACE also showed reduced levels of the synaptic protein discs large (DLG).
Enhancing sleep in memory-impaired APP:BACE ﬂies fully restored both STM and LTM and restored DLG
levels. Sleep also restored STM to ﬂies expressing human tau. Using live-brain imaging of individual clock
neurons expressing both tau and the cAMP sensor Epac1-camps, we found that tau disrupted cAMP signaling.
Importantly, enhancing sleep in ﬂies expressing human tau restored proper cAMP signaling. Thus, we
demonstrate that sleep can be used as a therapeutic to reverse deﬁcits that accrue during the expression of
toxic peptides associated with Alzheimer's disease.
1. Introduction
Alzheimer’s disease is a complex disorder that has been linked with
altered β-amyloid (Aβ) peptide processing, tau protein hyper-phos-
phorylation, inﬂammation, oxidative damage, reduced neurotrophins,
an alteration in the balance between excitatory and inhibitory synapses
and cognitive impairment leading to dementia (John and Berg, 2015;
Li et al., 2016). It has become increasingly clear that abnormal
phosphorylation of tau also plays a prominent role in the pathogenesis
of Alzheimer's disease (Fernandez-Funez et al., 2015). A crosstalk
between Aβ and tau has been demonstrated such that each may not
only exert their toxic eﬀects independently but also interact synergis-
tically (Nisbet et al., 2015). As a consequence, therapeutic interven-
tions that target either Aβ or tau separately may not be adequate to
fully treat the disorder (Fernandez-Funez et al., 2015; Nisbet et al.,
2015). In addition, recent studies suggest that Alzheimer's disease may
be a collection of distinct diseases that likely requires separate
therapeutic strategies (Ben-Gedalya et al., 2015; Vinters, 2015).
Clearly, the complexity of Alzheimer's pathology has hindered the
discovery of eﬀective therapeutics.
In recent years, there has been a growing interest in the relation-
ship between sleep and Alzheimer's pathogenesis (Xie et al., 2013; Roh
et al., 2014). Importantly, several groups have hypothesized that
improving sleep might be beneﬁcial for slowing or attenuating cogni-
tive deﬁcits during Alzheimer's disease (Sperling and Johnson, 2012;
Lucey and Holtzman, 2015; Musiek et al., 2015; Mander et al., 2016).
Indeed, sleep is well suited for addressing complex diseases that can
impact multiple physiological systems (Tononi and Cirelli, 2006; Imeri
and Opp, 2009; Stickgold and Walker, 2013). As a consequence, sleep
may be useful, even if indirectly, as a co-therapy to restore neuronal-
functioning.
We have shown that inducing sleep can reverse age-dependent
cognitive declines in Presenilin mutants (Psn), a Drosophila model of
Familial Alzheimer's disease (McBride et al., 2010; Dissel et al., 2015a).
In addition to restoring memory in Psnmutants, we reported that sleep
reversed cognitive deﬁcits in classic memory mutants with opposite
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neurophysiological deﬁcits (Dissel et al., 2015a). Since sleep can
independently improve memory from brains that are disrupted by
diﬀerent underlying mechanisms, our data indicate that sleep may
indeed be useful to oﬀset pathology associated with a complex disorder
such as Alzheimer's disease. However, a closer inspection of our data
indicates that while we have evaluated a diverse set of mutants, they
share a common feature. That is, the mutations we have studied
prevent a critical gene from carrying out its function (e.g. the adenylyl
cyclase mutant rutabaga and the phosphodiesterase mutant dunce)
(Dissel et al., 2015a). This stands in contrast to many degenerative
diseases in which a mutation leads to the accumulation of toxic
compounds that actively disrupt neuronal function over time.
In humans, Alzheimer's disease is associated with the progressive
accumulation of β-amyloid plaques, neuroﬁbrillary tangles, and loss of
synapses. These pathological hallmarks are due, at least in part, to the
accumulation of a toxic form of Aβ (Aβ42). While evidence suggests that
Drosophila Psn mutants may generate toxic Aβ fragments (Carmine-
Simmen et al., 2009), it is not clear whether these toxic fragments
accumulate without co-expressing human amyloid precursor protein
(APP) and the β-secretase enzyme involved in the processing of APP
(BACE). Thus, the ability of sleep to reverse memory impairments in
Psn mutants may not be an adequate test of our hypothesis that sleep
can be used as a therapeutic to reverse pathology in the context of
Alzheimer's disease. Moreover, the classic memory mutants we have
studied are impaired from their ﬁrst day of life and their memory
phenotype does not seem to worsen (Davis, 2011; Kahsai and Zars,
2011). Thus, in some respects, their phenotype is static. In contrast,
progressive diseases continuously change neuronal functioning thereby
requiring that the brain constantly adapt. If a fundamental role for
sleep is to modulate plasticity then sleep may be able to restore
adaptive behavior even when neuronal functioning is continuously
and progressively disrupted during degeneration. Alternatively, in-
creasing sleep may not be able to overcome pathology when it is due to
an active process as is the case for many degenerative diseases.
Determining whether sleep can inﬂuence degenerative processes is
critical for determining whether sleep can be used as a therapeutic.
There are several Drosophila models of Alzheimer's disease that
produce neurotoxic misfolded peptides/proteins that result in progres-
sive degeneration (Iijima et al., 2004; Mhatre et al., 2013; Fernandez-
Funez et al., 2015; Tabuchi et al., 2015). Several studies have reported
that co-expressing human amyloid precursor protein and β-secretase
results in the production of abnormal Aβ peptides in ﬂies, defective
synapses, and memory impairments (Carmine-Simmen et al., 2009;
Chakraborty et al., 2011; Mhatre et al., 2014; Bourdet et al., 2015). In
addition, the overexpression of human tau in ﬂy neurons results in age
dependent vacuolization, neuronal degeneration and memory impair-
ments (Wittmann et al., 2001; Mershin et al., 2004; Mhatre et al.,
2013). Thus, we will evaluate the ability of sleep to reverse pathology
and behavioral deﬁcits resulting from either the co-expression of
human APP and BACE or the overexpression of human tau.
2. Methods
2.1. Flies
Flies were cultured at 25 °C with 50–60% relative humidity and
kept on a diet of yeast, dark corn syrup and agar under a 12-h light:12-
h dark cycle. DaGsw-GAL4 were obtained from Marc Tater (Brown
University) and UAS-APP:BACE ﬂies were obtained from Daniel
Marenda (Drexel University), UAS-Epac1.camps and pdf-GAL4 lines
were obtained from Paul Taghert (Washington University in St. Louis),
UAS-tau were obtained from the Bloomington stock center.
2.2. Sleep
Sleep was assessed as previously described (Shaw et al., 2000).
Brieﬂy, ﬂies were placed into individual 65 mm tubes and all activity
was continuously measured through the Trikinetics Drosophila Activity
Monitoring System (www.Trikinetics.com, Waltham, Ma). Locomotor
activity was measured in 1-minute bins and sleep was deﬁned as
periods of quiescence lasting at least 5 min.
2.3. Sleep deprivation
Sleep deprivation was performed as previously described (Shaw
et al., 2002; Seugnet et al., 2008). Brieﬂy, ﬂies were placed into
individual 65 mm tubes and the sleep-nullifying apparatus (SNAP)
was used to sleep deprive these ﬂies for 12 h during the dark phase
(lights out to lights on). Sleep homeostasis was calculated for each
individual as a ratio of the minutes of sleep gained above baseline
during the 48 h of recovery divided by the total min of sleep lost during
12 h of sleep deprivation.
2.4. Short-term memory
Short-term memory (STM) was assessed by Aversive Phototaxic
Suppression (APS) as previously described (Seugnet et al., 2008, 2009).
The experimenters were blinded to conditions. In the APS, ﬂies are
individually placed in a T-maze and allowed to choose between a
lighted and darkened chamber over 16 trials. Flies that do not display
phototaxis during the ﬁrst block of 4 trials are excluded from further
analysis (Le Bourg and Buecher, 2002; Seugnet et al., 2009). During 16
trials, ﬂies learn to avoid the lighted chamber that is paired with an
aversive stimulus (quinine/ humidity). The performance index is
calculated as the percentage of times the ﬂy chooses the dark vial
during the last 4 trials of the 16-trial test. In the absence of quinine,
where no learning is possible, it is common to observe ﬂies choosing
the dark vial once during the last 4 trials in Block 4 (Seugnet et al.,
2009). In contrast, ﬂies never choose the dark vial 2 or more times
during Block 4 in the absence of quinine (Seugnet et al., 2009). Thus,
STM is deﬁned as two or more photonegative choices in Block 4. For
STM experiments following a 12 h sleep deprivation, the deprivation
continued until evaluation by the APS. All ﬂies were tested in the
morning. Power analysis using G*Power calculates a Cohen’s d of 1.8
and indicates that eight ﬂies/group are needed to obtain statistical
diﬀerences (Seugnet et al., 2009).
2.5. Photosensitivity
Photosensitivity was evaluated as previously described (Seugnet
et al., 2009). Brieﬂy, ﬂies were put in the T-maze over 10 trials in the
absence of ﬁlter paper. The lightened and darkened chambers appeared
equally on both the left and right. The photosensitivity index (PI) is the
average of the scores obtained for 5–6 ﬂies ± s.e.m.
2.6. Quinine sensitivity
Quinine sensitivity index (QSI) was evaluated as previously de-
scribed (Seugnet et al., 2008, 2009). Brieﬂy, ﬂies were individually
placed at the bottom of a 14 cm transparent cylindrical tube which was
uniformly lighted and maintained horizontal after the introduction of
the animal. Each half of the apparatus contained separate pieces of
ﬁlter paper which could be wetted with quinine or kept dry. The QSI
was determined by calculating the time in seconds that the ﬂy spent on
the dry side of the tube when the other side had been wetted with
quinine, during a 5 min period.
2.7. Courtship conditioning
Training for males was based on previously described methods
(Donlea et al., 2011). The males were exposed to a mated non-receptive
female using a training protocol consisting of three 1-h training
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sessions, each separated by one hour. Long-term memory was tested
forty-eight hours after the beginning of training, when trained and
naive males were exposed to virgin females for a 10-min testing period
(n=16–30 ﬂies/condition). The Courtship Index (CI) is deﬁned as the
percent of time that each subject ﬂy spends in courtship behavior
during the testing period. The CIs were subjected to an arcsine square
root transformation to approximate normal distribution as described in
(Ishimoto et al., 2013). Data are presented as a Performance Index
(PI), where PI=((CIaverage-naive−CI individual Trained)/CIaverage×100); PIs
were evaluated using the Kruskal-Wallis test. The experimenters were
blinded to condition. Vehicle-fed ﬂies were maintained on vehicle
throughout the experiment. For the 3-training session experiments
with drug (i.e. THIP (T))-induced sleep, naïve males were fed THIP
(0.1 mg/mL; 0.1 T) for 4 days prior to training. THIP-fed ﬂies were
removed from THIP 1 h prior to and during training (half of the 0.1T-
fed ﬂies were trained) and then returned to 0.1 T for 24 h post-training.
Vehicle-fed ﬂies were maintained on vehicle throughout the protocol.
2.8. Western blot
Sixteen ﬂy brains per group were dissected and homogenized in
15 µl cell lysis buﬀer (10 mM Tris, pH 8.5/8 M urea/4% CHAPS /5 mM
magnesium acetate) with 1x protease inhibitor cocktail (Roche).
Lysates were normalized for proteins (Bradford protein assay-Biorad
laboratories) and 1 µg of protein was mixed with sample buﬀer (4%
SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue
and 0.125 M Tris HCl, pH approx. 6.8 – Sigma Aldrich, St Louis, MO)
to a total of 12 µl. The samples were then heated to 100° Celsius for
5 min and then centrifuged for 3 min and loaded on a gradient gel (4–
15% TGX (Biorad)). Gel was run at 80 V for 1 h and 100 V until the
samples run oﬀ the gel and then transferred to PVDF membrane at 4 °C
at 100 v for 1.5 h. Blot was probed with Rabbit Anti-Amyloid Precursor
Protein (APP) antibody (Sigma Aldrich) 1:4000, mouse anti-TUBULIN
antibody (E7-βTUBULIN; - Developmental Studies Hybridoma Bank
University of Iowa)) 1:1000 followed by anti-rabbit secondary 1:1000
and anti-mouse secondary 1:1000 (Sigma Aldrich) respectively. Blot
was visualized using ECL HRP substrate (Thermoscientiﬁc) and a
Biorad chemiluminescence detector and quantiﬁed using ImageJ soft-
ware (NIH). After background correction, optical densities were
calculated and normalized (by dividing with the within-lane tubulin
signal used as loading control). The protein/tubulin ratio of the treated
samples was compared to the control lane in the same gel to measure
relative changes. Statistical analysis was performed using Student’s t-
test for two-group comparisons.
2.9. Pharmacology
THIP was administered at 0.1 mg/mL based upon a previous dose
response study (Dissel et al., 2015a). Flies were maintained on the drug
for the durations described in the text during which time sleep was
monitored. Flies were removed from THIP one hour prior to being
tested for short-term memory and one hour prior to being trained for
courtship conditioning.
2.10. Live brain imaging
Flies were chilled for approximately 5 min prior to pinning them
onto a sylgaard dissection dish. Brains were dissected in calcium-free
HL3 (Stewart et al., 1994) and then transferred onto a poly-lysine
treated dish (35×10 mm Falcon polystyrene) containing 3 ml of
1.5 mM calcium HL3. Two to four brains were assayed concurrently,
typically a mutant line and its genetic controls. Image capture was done
using an Olympus BX61 and x,y,z stage movements were set via
SLIDEBOOK 5.0 (Intelligent Imaging Innovations), which controlled a
Prior H105Plan Power Stage through a Prior ProScanII. Multiple YFP/
CFP ratio measurements were recorded in sequence from each brain in
the dish. Following baseline measurements, 1 ml of saline containing
either PDF or DA, was added to the bath (dilution factor of 1/4). We
used synthetic pigment dispersing factor, PDF, (Neo-MPS) and dopa-
mine (Sigma-Aldrich). For further details see (Shafer et al., 2008; Klose
et al., 2016).
2.11. Statistics
All comparisons were done using a Student's T-test or, if appro-
priate, ANOVA and subsequent planned comparisons using modiﬁed
Bonferroni test unless otherwise stated. Note that a signiﬁcant
omnibus-F is not a requirement for conducting planned comparisons
(Keppel, 1982). All statistically diﬀerent groups are deﬁned as *P <
0.05.
3. Results
3.1. Co- expression of human APP and BACE in adult ﬂies disrupts
nighttime sleep and short-term memory
When Alzheimer's related genes are expressed in a tissue- and age-
dependent manner using the bipartite GAL4-UAS system, ﬂies exhibit a
number of pathological hallmarks and behavioral impairments found
in human patients with Alzheimer's disease including age dependent
neurodegeneration, the accumulation of β-amyloid plaques, synaptic
deﬁcits, reduced life-span, and memory deﬁcits (Brand and Perrimon,
1993; Greeve et al., 2004; Chakraborty et al., 2011; Mhatre et al., 2013,
2014; Blake et al., 2015). Surprisingly, while sleep disturbances are a
common feature of Alzheimer's disease, very few studies have evalu-
ated the impact of Alzheimer's related abnormal proteins on sleep in
ﬂies (Dissel et al., 2015a; Tabuchi et al., 2015; Gerstner et al., 2016).
With that in mind, we examined sleep parameters in ﬂies co-expressing
human amyloid precursor protein (APP) and Beta-secretase (BACE)
(UAS-APP:BACE). To avoid potential confounds resulting from the
continuous expression of UAS-APP:BACE throughout development, we
used the GeneSwitch system to restrict the expression of APP:BACE to
adult ﬂies (Osterwalder et al., 2001; Mao et al., 2004). In the
GeneSwitch system, ﬂies must be fed a steroid, RU486 (RU), to
activate a GAL4-progesterone receptor fusion protein (Osterwalder
et al., 2001).
Parental controls, as well as experimental ﬂies, were maintained on
food containing either vehicle or RU for 5 days beginning on day 2
post-eclosion. Consistent with previous reports that RU, by itself, has
no eﬀect on sleep (Joiner et al., 2006; Seugnet et al., 2008) neither RU-
fed DaGsw/+ nor UAS-APP:BACE/+ parental controls showed
changes in sleep compared to their vehicle-fed siblings (Fig. 1A and
B). A 2(Veh, RU)×Time (24-h) repeated measure ANOVA did not
identify any signiﬁcant ‘drug’ by ‘time’ interactions (ANOVA
F[23,529]=0.53; p=0.79 and ANOVA F[23,437]=1.53; p=0.16, respec-
tively). In contrast, RU-fed DaGsw/+ >UAS-APP:BACE/+ ﬂies exhib-
ited signiﬁcant changes in sleep compared to vehicle fed siblings:
ANOVA F[23,1334]=3.13; p=8.70
E-07(Fig. 1C). Closer examination of
several sleep parameters including, sleep latency, daytime sleep, sleep
bout duration during the day and night, and the number of sleep bouts
revealed that the 5-days of adult expression of UAS-APP:BACE
predominantly disrupted sleep parameters during the night
(Fig. 1A′–C′; green panels). Thus, as with humans, Alzheimer's related
proteins also disrupt sleep in ﬂies.
Previous studies have reported that the co-expression of amyloid
precursor protein and β-secretase results in the production of Aβ
peptides in ﬂies (Carmine-Simmen et al., 2009; Chakraborty et al.,
2011; Mhatre et al., 2014). To conﬁrm that we could observe similar
results, we performed Western blot analysis to detect both full length
APP, ~110 kD (APP-FL), and Aβ C-terminal fragments (CTF),10–12
kD (CTF) in DaGsw-GAL4/+ >UAS-APP:BACE ﬂies. As seen in
Fig. 2A, extracts from RU-fed DaGsw-GAL4/+ >UAS-APP:BACE ﬂies
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(16 brains/sample) revealed both APP-FL (full length APP, ~110 kD)
and CTFs (~10 to 12 kD, using A8717 Sigma). Thus, RU-fed DaGsw-
GAL4/+ >UAS-APP:BACE ﬂies produce Aβ-CTF peptides similar to
that reported by others and that have been shown to give rise to
elevated levels of neurotoxic Aβ42 (Chakraborty et al., 2011).
To determine whether expressing β-CTF peptides would disrupt
short-term memory, we evaluated performance of DaGsw-GAL4/+ >
UAS-APP:BACE ﬂies and their parental controls using the well-
established Aversive Phototaxic Suppression Assay (APS) (Le Bourg
and Buecher, 2002; van Swinderen, 2011). In the APS, ﬂies are
individually placed in a T-maze and must learn to avoid a lighted
chamber that is paired with an aversive stimulus (quinine/humidity)
(Seugnet et al., 2008) (Fig. 2B). The performance index is calculated as
the percentage of times the ﬂy chooses the dark vial during the last 4
trials of the 16 trial test and STM is deﬁned as selecting the dark vial on
2 or more occasions during Block 4 (Dissel et al., 2015a, 2015b,
2015c). Before being tested for STM, ﬂies are ﬁrst tested to ensure that
they exhibit normal photosensitivity and quinine sensitivity (Le Bourg
and Buecher, 2002; Seugnet et al., 2008, 2009). This step is important
since changes to sensory thresholds could confound the ability to detect
true changes in associative learning (Kahsai and Zars, 2011; Dubnau
and Chiang, 2013; Dissel et al., 2015a). As seen in Fig. 2C and D, both
RU-fed and Vehicle-fed DaGsw/+ and UAS-APP:BACE/+ parental
controls display similar sensory thresholds. These data are consistent
with previous reports demonstrating that RU does not alter a variety of
behaviors including performance in the APS, olfactory conditioning,
phototaxis, geotaxis, locomotion, the escape response, sleep home-
ostasis, and quinine sensitivity (Mao et al., 2004; Joiner et al., 2006;
Seugnet et al., 2008; Dissel et al., 2015a; Thimgan et al., 2015).
Moreover, neither RU-fed nor Vehicle-fed DaGsw-GAL4/+ >UAS-
APP:BACE siblings show changes in photosensitivity or quinine
sensitivity, indicating that the expression of APP:BACE does not
disrupt sensory thresholds (Fig. 2E). Despite having normal sensory
thresholds, RU-fed DaGsw-GAL4/+ >UAS-APP:BACE ﬂies show a
signiﬁcant disruption in STM compared to vehicle-fed
siblings(Fig. 2H), while no changes in performance are seen between
RU and Vehicle-fed parental controls (Fig. 2F–G). Thus, the adult
expression of APP:BACE disrupts STM as measured by the APS.
DaGsw/+ UAS-APP:BACE/+ DaGsw/+>UAS-APP:BACE/+
Fig. 1. Conditional expression of APP:BACE in adults disrupts nighttime sleep. A–B) Seven-day old DaGsw-GAL4/+ and UAS-APP:BACE/+ parental controls that had been maintained
on RU exhibit similar sleep proﬁles compared to their Vehicle-fed siblings (n=11 ﬂies/condition). C) Seven-day old RU-fed DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies exhibited
signiﬁcantly disrupted sleep compared to Vehicle-fed siblings (n=28-30/condition). A′–B′) DaGsw-GAL4/+ and UAS-APP:BACE/+ ﬂies fed RU did not exhibit changes in sleep latency,
total sleep time, daytime sleep, night time sleep, the number of sleep bouts during the day or night or nighttime sleep compared to their vehicle-fed siblings; t-test. C′) RU fed DaGsw-
GAL4/+ >UAS-APP:BACE/+ ﬂies exhibited a decrease in total sleep time, and nighttime sleep compared to Vehicle-fed siblings. RU-fed DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies
exhibited a reduction in sleep bout duration at night and an increased number of sleep bouts compared to Vehicle-fed siblings; t-test. Sample size is the same as above; green panels
indicate parameters that are signiﬁcantly diﬀerent from Vehicle-fed controls. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version
of this article.)
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3.2. Enhancing sleep reverses short-term memory deﬁcits ﬂies
expressing APP:BACE
Recent studies in humans suggest that improving sleep might be
beneﬁcial for slowing or attenuating deﬁcits associated with
Alzheimer's disease in humans (Sperling and Johnson, 2012; Roh
et al., 2014). Consistent with this hypothesis, we have shown that 2-
days of sleep enhancement can reverse age-dependent cognitive
declines in Presenilin mutants (Psn) (Dissel et al., 2015a). Although
these latter data are encouraging, it is not clear whether toxic peptide
fragments accumulate in Psn mutants without co-expressing APP and
BACE (Carmine-Simmen et al., 2009). Thus, we asked whether sleep
could reverse STM deﬁcits in DaGsw-GAL4/+ >UAS-APP:BACE/+
ﬂies. Flies were maintained on either Vehicle or RU from day-2 post-
eclosion until they were 12-days of age. The ﬂies were then switched to
food containing 0.1 mg/mL of the GABA-A agonist THIP for two
additional days (RU0.1T, veh0.1T). As seen in Fig. 3A and B, THIP
retained its ability to increase sleep in RU-fed DaGsw-GAL4/+ >UAS-
APP:BACE/+ ﬂies compared to Vehicle-fed controls indicating that the
sleep regulatory circuits remained accessible at this stage of pathology.
A 2(RU, Veh) by 2(Veh, THIP)×24 (time) repeated measures ANOVA
revealed a signiﬁcant interaction; ANOVA F[23,3795]=1.74; p=0.015.
Importantly, THIP also increased sleep consolidation at night during
the ﬂy's primary sleep period (Fig. 3C). Thus, THIP can be used to
enhance sleep in 14 day-old ﬂies over-expressing APP:BACE.
To determine whether THIP-induced sleep could reverse cognitive
impairments, we also examined the performance of 14-day old DaGsw-
GAL4/+ >UAS-APP:BACE/+ ﬂies in the APS. Consistent with previous
reports that ﬂies do not show impairments in the APS during natural
aging (Le Bourg, 2004), neither vehicle nor veh0.1T fed DaGsw-GAL4/
+ >UAS-APP:BACE/+ ﬂies showed performance decrements (Fig. 3D).
In contrast to their vehicle-fed siblings, 14 day-old DaGsw-GAL4/+ >
UAS-APP:BACE/+ ﬂies maintained on RU exhibited impaired STM
(Fig. 3E, black). Importantly, two days of THIP-induced sleep (RU0.1T)
beginning on day 12 reversed STM deﬁcits (Fig. 3E, white). To
determine whether the improvements in performance were due to
increases in sleep per se or due to non-speciﬁc eﬀects of the drug, ﬂies
were sleep deprived while on THIP. In the absence of sleep, THIP did
not restore STM (Fig. 3F). Neither RU, nor THIP altered photosensi-
tivity or quinine sensitivity indicating that the improved performance
was due to speciﬁc changes in STM and not to changes in sensory
thresholds (Fig. 3G). To determine what impact THIP might have on
the processing of APP, we used Western blot analysis to evaluate the
expression of APP-FL and APP-CTF. As seen in Fig. 3H and I, following
sleep enhancement by THIP treatment, the levels of APP-CTF were
reduced while full length APP levels remained unchanged. Thus,
enhancing sleep can reverse cognitive deﬁcits in ﬂies co-expressing
human APP and BACE and reduced Aβ C-terminal fragments which are
known to be further cleaved in the toxic Aβ fragments.
Fig. 2. Conditional expression of APP:BACE in adults disrupts short-term memory. A) Western blot analysis of human APP and ﬂy tubulin detected in brains (16 brains/sample) of RU-
fed DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies. APP-FL (full length APP, ~110 kD) and APP-CTFs (C-terminal fragments, ~10 to 12 kD) were detected using A8717. B) Image of the APS.
C–E) No statistical diﬀerences in photosensitivity or quinine sensitivity were found between RU and Vehicle fed siblings of any genotype; t-test; n=6 ﬂies/condition F) 7-day old RU-fed
DaGsw-GAL4/+ parental controls perform identically in the APS compared to their Vehicle fed siblings (n=8 ﬂies/group; t-test). G) 7-day old RU and Vehicle-fed UAS-APP:BACE/+
ﬂies obtain statistically similar performance scores in the APS (n=8 ﬂies/group; t-test). H) 7-day old RU-fed DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies display performance deﬁcits in
the APS compared to vehicle-fed siblings (n=8 ﬂies/group; *p < 0.05, t-test).
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3.3. Enhancing sleep reverses long-term memory deﬁcits ﬂies
expressing APP:BACE
Although it is clear that independent memory assays cannot be used
to validate each other, not all memory tasks are likely to beneﬁt from
sleep. Thus, we investigated whether inducing sleep may be beneﬁcial
for an additional and ethologically relevant memory assay (McBride
et al., 2005, 2010). Previous studies have found that the pan-neuronal
expression of APP:BACE resulted in deﬁcits in short-term memory as
assessed using courtship conditioning but the eﬀects on long-term
memory (LTM) using courtship memory remain unknown
(Chakraborty et al., 2011). In courtship conditioning, a naïve male ﬂy
is exposed to a mated, non-receptive female who rejects his advances;
associative memories are detected by a subsequent reduction in court-
ship when exposed to a receptive female (Fig. 4A) (Donlea et al., 2011,
2012; Dissel et al., 2015a). To evaluate LTM, ﬂies are exposed to three
one-hour training sessions, each separated by one hour; reductions in
courtship (e.g., LTM) can be found several days later. To evaluate the
eﬀects of sleep on LTM in DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies,
naïve males were maintained on RU until they were 12 days of age as
above (Fig. 4B). On day 12, ﬂies were placed onto food containing both
RU and 0.1 mg/mL of THIP (RU0.1T) for 4 days. Flies were removed
from THIP during training to ensure that they wouldn’t be too
somnolent to exhibit normal courtship (Dissel et al., 2015a)
(Fig. 4B). A negative-rebound is observed immediately following
removal from THIP (Dissel et al., 2015a). As a consequence, ﬂies were
Fig. 3. THIP-induced sleep restores performance to 14-day old DaGsw/+ >UAS-APP:BACE/+ ﬂies A) DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies were maintained on Vehicle until day
12 and then randomly assigned to two groups for 2 additional days; one group was maintained on Vehicle (Veh), the other was placed on to food containing 0.1 mg/ml THIP (Veh0.1T).
Flies maintained on Veh0.1T slept signiﬁcantly more than their Vehicle-fed siblings (n=42/condition). B) DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies were placed on to food containing RU
for 10 days beginning on day 2 post eclosion. RU fed ﬂies were then randomly assigned to two groups for 2 days; one group was maintained on RU (RU), the other was placed on to RU-
food containing 0.1 mg/mL THIP (RU0.1T). Flies maintained on RU0.1T slept signiﬁcantly more than their RU-fed siblings (n=42/condition). C) THIP administration signiﬁcantly
increased sleep consolidation at night in DaGsw/+ >UAS-APP:BACE/+ ﬂies maintained on Veh0.1T and RU0.1T; n=42 / condition. D) STM is not modiﬁed in 14-day old DaGsw-GAL4/
+ >UAS-APP:BACE/+ ﬂies maintained on Veh or Veh0.1T (n=8 ﬂies/group; t-test). E) Two-days of THIP-enhanced sleep restores STM to RU0.1T DaGsw-GAL4/+ >UAS-APP:BACE/+
ﬂies compared to RU-fed siblings (n=8 ﬂies/group; *p < 0.05, t-test). F) Sleep deprived DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies maintained on RU0.1T did not show improvements in
STM compared to non-sleep deprived RU0.1T controls (n=8 ﬂies/group; *p < 0.05, t-test). G) Neither RU, nor THIP signiﬁcantly modiﬁed photosensitivity or quinine sensitivity (n=5–6
ﬂies/group, t-test). H) Western blot analysis of human APP and ﬂy β-actin detected in brains (16 brains/sample) of DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies. APP-FL (full length APP,
~110 kD) and APP-CTFs (C terminal fragments, ~10 to 12 kD) were detected using A8717 (Sigma) as described in Chakraborty et al. (2011) C). I) Quantiﬁcation of APP-FL in RU and
RU0.1T siblings (n=4 samples/condition).
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placed back onto RU0.1T food for 24 h following training to prevent the
negative rebound from occurring during memory consolidation (Dissel
et al., 2015a). After 24 h, ﬂies were placed onto food containing only
RU for 24 h before being tested for LTM (Fig. 4B).
An increase in sleep is frequently observed directly after training in
ﬂies that subsequently exhibit an LTM 48-h later (Ganguly-Fitzgerald
et al., 2006; Donlea et al., 2011). Thus, we asked whether RU or RU0.1T
ﬂies would show an increase in sleep consolidation in the hours
following training. Interestingly, RU-fed DaGsw-GAL4/+ >UAS-
APP:BACE/+ ﬂies displayed a deﬁcit in their ability to consolidate
sleep following training compared to their THIP fed siblings (Fig. 4C).
Not surprisingly then, RU-fed DaGsw-GAL4/+ >UAS-APP:BACE/+
ﬂies also displayed deﬁcits in LTM compared to their vehicle-fed
siblings (Fig. 4D). In contrast, RU0.1T ﬂies exhibited courtship memory
that was not signiﬁcantly diﬀerent from healthy, vehicle fed siblings
(Fig. 4D); a 2 (veh, RU)×2 (veh, THIP) two-way ANOVA revealed a
signiﬁcant interaction ANOVA F[1,67]=6.84; p=0.011. Krustal-Wallis,
p=0.001. Thus, increasing sleep restores cognitive behavior when
assessed using two independent memory assays that utilize diﬀerent
sensory modalities and neuronal circuits.
3.4. Sleep reverses synaptic deﬁcits in ﬂies expressing APP:BACE
The co-expression of APP and BACE has been reported to damage
synapses (Mhatre et al., 2014). Thus we examined whether THIP-
induced sleep would impact the expression of the synaptic protein discs
large (DLG). As seen in Fig. 5, levels of DLG protein were reduced in
RU-fed 14-d old DaGsw-GAL4/+ >UAS-APP:BACE/+ ﬂies compared
to vehicle-fed siblings. Importantly, DLG levels return to baseline
following THIP-induced sleep (Fig. 5A–B). A 2(Veh, RU)×2 (Veh,
0.1 T) ANOVA revealed a signiﬁcant drug (Veh, Ru)×drug (Veh, 0.1 T)
Fig. 4. THIP-induced sleep restores Long-Term Memory (LTM) to 14-day old DaGsw/+ >UAS-APP:BACE/+ ﬂies A) Schematic of courtship conditioning (see text for details). B)
Protocol for the timing of administration of RU, THIP, and training. Vehicle-fed ﬂies were maintained on Vehicle throughout the experiment (black); RU fed ﬂies were placed onto RU
beginning on Day 2 post-eclosion (red). Flies treated with 0.1 mg/mL THIP were placed onto RU on Day 2 post-eclosion and switched to food containing both RU and THIP (RU0.1T) for
4 days beginning on day 12 and again for 24 h after training (Red). C) Sleep bout duration measured between the end of training and lights out (Zeitgeber time 12) for each group of
trained ﬂies (Vehicle, RU and RU0.1T) expressed as a percentage change from trained Vehicle-fed siblings. RU0.1T DaGsw/+ >UAS-APP:BACE/+ ﬂies initiated signiﬁcantly longer sleep
bouts following training than RU fed siblings; n=18-19 ﬂies/ condition; *p < 0.05, t-test. D) RU-fed DaGsw/+ >UAS-APP:BACE/+ ﬂies did not show evidence of LTM as indicated by a
signiﬁcantly reduced performance index (PI) compared to both Vehicle-fed ﬂies, vehicle-fed ﬂies maintained on 0.1 mg/mL of THIP (veh0.1T), or RU0.1T siblings; a 2 (veh, RU)×2 (veh,
THIP) two-way ANOVA, n=17-18 ﬂies/group, *p < 0.05 modiﬁed Bonferroni test. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
Fig. 5. Sleep restores the levels of the synaptic protein discs large (DLG) in DaGsw/+ >
APP:BACE/+ ﬂies. A) Western blot of DaGsw/+ > APP:BACE/+ ﬂies maintained on
Vehicle or RU, and Vehicle and RU with 0.1 mg/mL of THIP (Veh0.1T, RU0.1T); (6 brains/
sample). RU-fed ﬂies show reduced DLG protein compared to their vehicle fed siblings.
B) Quantiﬁcation of DLG. Following THIP induced sleep, DLG levels return to baseline
(RU0.1T); *p < 0.05, modiﬁed Bonferroni test.
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interaction; ANOVA F[1,4]=78.67; p=0.05. Together these data suggest
that sleep can beneﬁts both physiology and behavior in ﬂies co-
expressing human APP and BACE.
3.5. Enhancing sleep reverses memory deﬁcits ﬂies expressing human
Tau
As mentioned above, it has become increasingly clear that tau also
plays a prominent role in the pathogenesis of Alzheimer's disease
(Fernandez-Funez et al., 2015). We have previously reported age-
dependent cognitive decline in ﬂies expressing UAS-tau under the
control of the MBGeneSwitch-GAL4 driver (Seugnet et al., 2009). Thus,
we asked whether sleep might also be beneﬁcial to ﬂies expressing
UAS-tau. To allow comparisons with the APP:BACE data presented
above, we used the Daughterless-GeneSwitch-GAL4 (DaGsw) driver to
express UAS-tau in adult ﬂies after 5 days of RU administration. As
seen in Fig. 6A, sleep in RU-fed DaGsw/+ >UAS-tau/+ ﬂies was
signiﬁcantly diﬀerent than Vehicle-fed siblings; A 2(Vehicle, RU) X 24
(time) ANOVA revealed a signiﬁcant Drug X Time interaction ANOVA
F[23,1357]=5.86; p=9.99E-16. RU-fed DaGsw/+ >UAS-tau/+ ﬂies
showed signiﬁcant reductions in total sleep time (Fig. 6B).
Surprisingly, and in contrast to APP:BACE expression, sleep was
signiﬁcantly reduced during the day but not the night and other sleep
parameters (e.g., sleep latency, sleep bout duration) were not signiﬁ-
cantly altered (data not shown). These data suggest that APP:BACE and
tau diﬀerentially modify sleep circuitry. Identifying how these proteins
diﬀer will be an interesting topic for future investigations.
Although our data suggest that sleep can be beneﬁcial for ﬂies
mutant for Presenilin or ﬂies expressing APP:BACE, the pathophysiol-
ogy of tau may be diﬃcult to reverse. Thus, we examined STM in
DaGsw/+ >UAS-tau/+ after 5 days of RU administration. As seen in
Fig. 6C, RU-fed DaGsw/+ >UAS-tau/+ ﬂies showed signiﬁcantly
impaired STM in the APS compared to vehicle-fed siblings and these
deﬁcits were reversed following two days of THIP-induced sleep; a
One-way ANOVA revealed a main eﬀect for treatment (Veh, RU, RU0.T)
F[2,48]=4.2; p=0.02. Importantly, photosensitivity and quinine sensi-
tivity were statistically similar in DaGsw/+ >UAS-tau/+ siblings
maintained on Vehicle, RU, or RU0.T (Fig. 6D) indicating that the
changes in performance were due to associative learning and not
confounding alterations in sensory thresholds. Thus, sleep can reverse
cognitive impairments in Psn mutants, as well as ﬂies co-expressing
human APP and BACE and ﬂies overexpressing tau.
3.6. Enhancing sleep reverses cAMP signaling deﬁcits in clock
neurons expressing tau
Several elegant studies have recently shown that expressing trans-
genic Alzheimer's related genes in clock neurons can alter morphology,
physiology and behavior (Chen et al., 2014; Blake et al., 2015; Bouleau
and Tricoire, 2015). Thus, we wished to examine the anatomical and
physiological consequences of expressing UAS-tau in clock neurons.
Given the important role that the large-and small ventral lateral
neurons (lLNvs, sLNvs) play in regulating sleep and waking, as well
as the circadian clock (Parisky et al., 2008; Shang et al., 2008; Sheeba
et al., 2008; Chung et al., 2009), we determined if expressing UAS-tau
altered the physiological properties of lLNvs and whether any such
changes could be modulated by sleep. Several studies have used live-
brain imaging to deﬁne cAMP response properties in individual LNvs
neurons with Epac1-camps (Shafer et al., 2008; Shang et al., 2008;
Shang et al., 2011; Klose et al., 2016). Thus, we expressed UAS-Epac1-
camps using pdf-GAL4 and examined cAMP responses in lLNvs in
response to dopamine. To begin we asked whether THIP could increase
sleep in pdf-GAL4/+ >UAS-Epac; UAS-tau/+ ﬂies. As seen in Fig. 7A–
C, THIP increased both total sleep time and sleep consolidation during
the day compared to age-matched, vehicle-fed siblings. Consistent with
previous reports, dopamine modulates cAMP levels in single LNv
neurons (Fig. 7D,E). Importantly, the cAMP responses of LNv neurons
are not modulated in ﬂies maintained on 0.1 mg/mL of THIP for two
days (Fig. 7E). Expressing tau in pdf-GAL4 >UAS-Epac-camps expres-
sing neurons substantially reduced the increase in cAMP usually seen
Fig. 6. THIP-induced sleep restores Short -Term Memory (STM) to DaGsw/+ >UAS-tau/+ ﬂies. A) Sleep in RU-fed DaGsw/+ >UAS-tau/+ ﬂies was signiﬁcantly diﬀerent from
Vehicle-fed siblings; n=27–32 ﬂies/condition. B) Total Sleep Time was signiﬁcantly reduced in RU-fed DaGsw/+ >UAS-tau/+ ﬂies compared to Vehicle-fed siblings; n=27–32 ﬂies/
condition; p < 0.05, t-test. C) RU-fed DaGsw/+ >UAS-tau/+ ﬂies exhibited disrupted STM compared to Vehicle-fed siblings and siblings maintained on RU and THIP for 2 days (n=13–
19 ﬂies/group); *p < 0.05, modiﬁed Bonferroni test. D) Neither RU, nor THIP signiﬁcantly modiﬁed altered photosensitivity or quinine sensitivity ANOVA F[2,15]=0; p=1 and ANOVA
F[2,14]=3.6; p=0.058, respectively (n=5–6 ﬂies/group).
S. Dissel et al. Neurobiology of Sleep and Circadian Rhythms xx (xxxx) xxxx–xxxx
8
following the administration of Dopamine (DA; Fig. 7F, red) (Shang
et al., 2011). Interestingly, ﬁve days of THIP- induced sleep can restore
the response properties of clock neurons (Fig. 7F green).
4. Discussion
In the present study, we tested the hypothesis that sleep could be
used as a therapeutic to reverse memory impairments and the under-
lying pathology in Drosophila models of Alzheimer's disease. We used
two established models of Alzheimer's disease previously shown to
produce memory impairments and age-dependent brain degeneration
(Wittmann et al., 2001; Chakraborty et al., 2011; Mhatre et al., 2013,
2014). Each of the Alzheimer's model evaluated, human APP:BACE
and tau mutants, disrupted sleep and produced memory impairments.
Although recent studies suggest that the onset of Alzheimer's pathology
can be delayed by preventing sleep deﬁcits (Ju et al., 2013; Yaﬀe et al.,
2014), we wished to know whether sleep could also reverse these
deﬁcits after the onset of pathology had been established. The ability to
reverse aspects of Alzheimer's pathology could prove valuable since it is
frequently diﬃcult to diagnose and treat the disorder prior to the point
where pathology is clearly evident (Ryman et al., 2014). Our data
indicate that enhancing sleep can reverse both behavioral and physio-
logical deﬁcits in Alzheimer's ﬂies.
Recent studies have focused on a prophylactic role of preventing
sleep deﬁcits in treating Alzheimer's disease (Musiek et al., 2015). That
is, current-hypotheses propose that sleep disturbances early in life
might aggravate Alzheimer's pathology in susceptible individuals (Kang
et al., 2009; Yaﬀe et al., 2014; Colby-Milley et al., 2015; Tabuchi et al.,
2015; Branger et al., 2016). This view is supported by a growing body
of data in humans, rodents and ﬂies. Indeed, acute sleep deprivation
increased levels of Aβ in the interstitial ﬂuid of in Tg2576 mice, while
chronic sleep restriction signiﬁcantly and enhanced Aβ plaque deposi-
tion (Kang et al., 2009). Moreover, when sleep was chronically
disrupted in 3xTg mice, which express PS1(M146V), APP(Swe), and
tau(P301L) transgenes, they exhibited signiﬁcant memory impair-
ments, altered tau metabolism, and lower levels of the post-synaptic
density protein 95 (PSD95) (Di Meco et al., 2014). An increase in Aβ
and Tau levels were also found in the cortex of 3xTg mice undergoing
chronic sleep restriction for 6 weeks (Rothman et al., 2013).
Interestingly, in humans, poor sleep quality in pre-clinical patients is
associated with increased amyloid deposition (Ju et al., 2013; Branger
et al., 2016). In addition, women with sleep disrupted breathing show
an increased risk of developing cognitive impairment or dementia
(Yaﬀe et al., 2011). Importantly, sleep deprivation also increases Aβ
burden in ﬂy models of Alzheimer's disease (Tabuchi et al., 2015). The
observation that insuﬃcient sleep aggravates Alzheimer's pathology
across such diverse species highlights the importance of sleep deﬁcits
in disease progression.
Sleep disturbances are common features of Alzheimer's disease.
Thus, even for individuals that may not have experienced sleep-
Fig. 7. Sleep reverses the abnormal response properties of ventrolateral clock neurons (LNvs) expressing tau. A) pdf-GAL4/+ >UAS-Epac; UAS-tau/+ ﬂies increased sleep when placed
onto 0.1 T; 2 (Veh, 0.1 T)×24 (time) repeated measures ANOVA F[23,506]=6.94; p=9.99
E-16; n=12 ﬂies/condition. B) Total Sleep Time was signiﬁcantly increased in 0.1 T fed pdf-GAL4/
+ >UAS-Epac; ﬂies compared to Vehicle-fed siblings; n=12 ﬂies/condition; p=9.25E-06, t-test. C) Daytime sleep bout duration was signiﬁcantly increased in 0.1 T fed pdf-GAL4/+ >
UAS-Epac ﬂies compared to Vehicle-fed siblings; n=12 ﬂies/condition; p=5.6E-04, t-test. D) Confocal image of pdf-GAL4 > GFP ﬂies showing the location of the LNvs E) THIP-induced
sleep does not alter cAMP levels in wild-type pdf > Epac-camps ﬂies in response to 3e-5M Dopamine(DA). F) Expressing UAS-tau reduces the change in cAMP in response to DA (red)
compared to controls (blue). Interestingly, 5 days of THIP-induced sleep fully restored cAMP levels to normal in ﬂies expressing tau (green). (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
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disturbances early in life, sleep will most likely be disrupted when
Alzheimer's related neural degeneration begins to impact sleep and
circadian circuits (Colby-Milley et al., 2015; Branger et al., 2016).
Unfortunately, ameliorating sleep deﬁcits in this population is diﬃcult
(see Musiek et al. (2015) for discussion). Given the increased risk of
adverse events when older adults are administered sedative-hypnotics,
few studies have systematically examined the impact of long-term use
of sleep agents during Alzheimer's disease. Interestingly, two weeks of
Trazadone administration improved both sleep and circadian para-
meters in Alzheimer's patients (Camargos et al., 2014; Grippe et al.,
2015). Unfortunately, two weeks of Trazadone did not improve
cognition in these individuals (Camargos et al., 2014). In rodents, the
administration of Almorexant signiﬁcantly reduced Aβ plaque forma-
tion in Tg2576 mice suggesting that hypocretin/orexin antagonists
might be useful for ameliorating some Alzheimer's pathology (Kang
et al., 2009). Interestingly, increasing sleep by administering Growth
Hormone-releasing hormone in transgenic mice that overexpress
mutant forms of APP and PSEN1 also resulted in a decrease in Aβ
levels suggesting that hypnotics, in general, may eventually prove
useful in oﬀsetting some Alzheimer's pathology (Liao et al., 2015).
However, hypnotics can also have a negative impact on plasticity and
identifying an appropriate compound that can increase sleep but does
not also produce negative side-eﬀects is non-trivial (Aton et al., 2009;
Vienne et al., 2012). If too many side-eﬀects are found with currently
available hypnotics, it will be of interest to determine whether newer
genetic methods for enhancing sleep in rodents can reverse/attenuate
or slow-down Alzheimer's pathology in rodent models (Jego et al.,
2013; Konadhode et al., 2013; Anaclet et al., 2014).
Although we have identiﬁed genetic tools that can be used to
enhance sleep in Drosophila (Donlea et al., 2011), a goal of the present
study is to determine whether pharmacological agents might be useful
for increasing sleep in the context of Alzheimer's related memory
impairments. Clearly, a pharmacological agent will be required if sleep
is to be useful as a therapeutic for treating Alzheimer's disease in
humans (Musiek et al., 2015). Thus, we chose to enhance sleep
pharmacologically by administering the GABA-A agonist THIP. THIP
has recently been identiﬁed as a powerful sleep promoting agent in ﬂies
(Berry et al., 2015; Dissel et al., 2015a). THIP increases sleep-time as
well as sleep-consolidation via the Ligand-gated chloride channel
homolog 3 and the Glycine receptor GABA-A receptors which have
homology with human GABA-A beta3 and alpha6 subunits, respec-
tively (Dissel et al., 2015a) (http://www.ﬂyrnai.org/diopt).
Importantly, the sleep seen following THIP administration meets all
of the criteria needed for identifying sleep including increased arousal
thresholds, rapid reversibility and homeostatic regulation (Hendricks
et al., 2000; Shaw et al., 2000). Moreover, the sleep induced by THIP
produces similar eﬀects on molecular and physiological parameters
that are modulated by spontaneous sleep including synaptic markers,
immune-related transcripts and changes in local ﬁeld potentials (van
Alphen et al., 2013; Dissel et al., 2015a). Indeed, while THIP
substantially increases sleep, the total amount of sleep and sleep
architecture observed closely resemble other conditions of high sleep
drive such as during recovery sleep following sleep deprivation, sleep
during the early stages of adult life, sleep following social enrichment,
and sleep following training protocols that induce LTM using courtship
conditioning (Donlea et al., 2009; Seugnet et al., 2011; Thimgan et al.,
2015). Importantly, the eﬀects of THIP-induced sleep have been shown
to be identical to that observed using two molecularly-distinct methods
of genetically-increasing sleep (Berry et al., 2015; Dissel et al., 2015a).
Together with the observation that the beneﬁcial eﬀects of THIP are
not observed in the absence of sleep (Fig. 3F and Dissel et al. (2015a)),
the data strongly indicates that the beneﬁts of THIP are due to sleep-
itself and not due to non-speciﬁc eﬀects of the drug. In fact, our data
using THIP to reverse Alzheimer's pathology are consistent with a
recent report showing that genetically-enhancing sleep reduces Aβ
deposition in ﬂies (Tabuchi et al., 2015). Thus, these results provide
proof-of-principle data that sleep can be enhanced pharmacologically
to oﬀset pathology associated with Alzheimer's disease.
Discovery experiments intended to better elucidate the pathophy-
siology of Alzheimer's disease have been hampered both by the
complexity of the disorder and also by the fact that Alzheimer's
pathology does not impact all types of neurons equally. An advantage
of using Drosophila is that tools are available to monitor the structure
and physiology of speciﬁc, genetically-accessible neurons. A set of 16
clock neurons, known as the small and large ventral lateral neurons
(sLNVs and lLNvs, respectively) are well suited for elucidating the
relationship between sleep and Alzheimer's disease. First, these clock
neurons inﬂuence a surprising number of important behaviors (e.g.,
memory, sleep, social enrichment, age-dependent cognitive decline,
ethanol sensitivity, cocaine sensitization) (Andretic et al., 1999; Shang
et al., 2008; Donlea et al., 2009; Eddison et al., 2011; Donlea et al.,
2014). Second, clock neurons display stereotyped, plastic changes in
their anatomical projection patterns that can be easily quantiﬁed
during disease and subsequent therapeutic interventions (Fernandez
et al., 2008). Third, the physiological properties of individual clock
neurons can be quantiﬁed using a variety of imaging techniques to
better understand their underlying physiology (Shafer et al., 2008; Yao
et al., 2012; Cao et al., 2013). Fourth, clock neurons have been the
subject of several intensive transcriptomic studies and thus a great deal
is known about genes that are present in these neurons (Kula-Eversole
et al., 2010; Hadzic et al., 2015; Petsakou et al., 2015). Finally, recent
studies have found that expressing transgenic Alzheimer's related
genes in clock neurons can alter their morphology, physiology and
behavior, sometimes in surprising ways (Pirooznia et al., 2012; Chen
et al., 2014; Blake et al., 2015; Bouleau and Tricoire 2015; Tabuchi
et al., 2015). Since previous studies had focused on the behavioral,
physiological and molecular eﬀects of APP processing and the expres-
sion of Aβ-like peptides in clock neurons (Chen et al., 2014; Blake
et al., 2015; Tabuchi et al., 2015), we examined the physiological
consequences of expressing human tau. The overexpression of human
tau had profound negative eﬀects on the physiology of LNv neurons as
indicated by reduced cAMP signaling in response to dopamine. Clock
neurons are believed to support behavioral ﬂexibility by regulating the
integration of diverse environmental cues across the circadian day
(Shang et al., 2011; Choi et al., 2012; Duvall and Taghert, 2012; Zhang
and Emery, 2013). Within clock neurons, both the dopamine receptor
and pigment dispersing factor receptor (Pdfr) exert their eﬀects, in
part, by modulating cAMP (Shafer et al., 2008; Shang et al., 2011; Li
et al., 2014). Indeed, the ability of the clock to gate when external
signals can drive cAMP oscillations may be crucial for synchronizing
circadian circuits. (Collins et al., 2014). In addition to its role in
circadian behavior, cAMP also plays important role in sleep and
memory consolidation (Hendricks et al., 2001; Havekes et al., 2016).
Thus, by restoring cAMP signaling in w;pdf > Epac; tau, ﬂies sleep has
the potential to positively inﬂuence a number of important behaviors
regulated by the clock. Nonetheless, these data emphasize that sleep
can restore normal functioning to unhealthy neurons expressing a toxic
protein. How sleep restores the response of clock neurons to cAMP and
whether sleep improves behavior by modulating other signaling path-
ways will undoubtedly be addressed in future studies.
We have shown that pharmacologically enhancing sleep can reverse
cognitive deﬁcits in mutants with opposing neurophysiological deﬁcits
without repairing the precise underlying genetic lesion (Dissel et al.,
2015a). The observation that sleep can independently restore memory
when brains are disrupted in diﬀerent ways, suggests that sleep may
play a more fundamental role in modulating plasticity than has been
previously recognized. This observation may have several potential
ramiﬁcations for treating Alzheimer's disease. First, sleep is well suited
for treating a complex disease that involves more than one toxic protein
and that can impact multiple physiological systems. Second, sleep may
be useful as a co-therapy in conjunction with promising compounds
that may produce negative side eﬀects on their own (Vassar 2014;
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Blake et al., 2015). That is, sleep may not only reduce the pathology
associated with Alzheimer's disease (thereby allowing for lower doses
of the therapeutic) it may also work independently to oﬀset any
negative side-eﬀects of the therapeutic compound. Third, sleep may
be beneﬁcial, even if indirectly, by restoring neuronal-functioning
suﬃciently to re-open the therapeutic window for patients whose
disease has progressed beyond the point where compounds can be
eﬀective. Fourth, identifying the molecular mechanisms underlying the
positive eﬀects of sleep may create additional treatment opportunities
for slowing or oﬀsetting disease progression. Together with the recent
work by other labs (Kang et al., 2009; Chen et al., 2014; Mhatre et al.,
2014; Blake et al., 2015; Tabuchi et al., 2015), these data provide new
avenues for harnessing the power of Drosophila to better understand
the therapeutic potential of sleep for reversing the pathophysiology of
Alzheimer's disease.
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